Personal profile
Headline
PROFESSOR | Medicine, Hematology and Medical Oncology
Biography
Sundar Jagannath, MD, is Director of the Multiple Myeloma Program and Professor of Medicine (Hematology and Medical Oncology) at The Tisch Cancer Institute. Dr. Jagannath is a renowned expert in the research and treatment of multiple myeloma — a relatively rare cancer of the bone marrow. Prior to joining Mount Sinai, Dr. Jagannath served as chief of the multiple myeloma and transplant program at St. Vincent’s Hospital Comprehensive Cancer Center from 1998 until the hospital closed in April 2010. The transplant program, with stored stem cells of more than 300 patients, and the myeloma program with ongoing clinical trials, have been integrated into The Tisch Cancer Institute. Mount Sinai’s Multiple Myeloma Program provides clinical care to a large patient population, including the transfer of more than 800 patients who had been receiving care at St. Vincent’s. Dr. Jagannath has published more than 180 peer-reviewed articles in top publications, including the New England Journal of Medicine, Blood, the Journal of Clinical Oncology and Cancer. He has presented more than 150 abstracts and authored nearly 30 book chapters.
Fingerprint
Dive into the research topics where Sundar Jagannath is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy bb21217 for Relapsed and Refractory Multiple Myeloma: Results from the Phase I CRB-402 Study
Alsina, M., Shah, N., Jagannath, S., Kaufman, J. L., Siegel, D., Munshi, N. C., Rosenblatt, J., Lin, Y., Jakubowiak, A. J., Derman, B. A., Li, A., Mao, P., Fincker, M., Yeri, A., Martin, N., Campbell, T. B., Finney, O., Truppel-Hartmann, A., Petrocca, F. & Berdeja, J. G. & 1 others, , 1 Apr 2026, In: Cancer Immunology Research. 14, 4, p. 528-542 15 p.Research output: Contribution to journal › Article › peer-review
-
Baseline absolute lymphocyte count, C-reactive protein, and ferritin predict CAR T cell-related toxicities and outcomes in multiple myeloma
Pan, D., Mouhieddine, T. H., Sheng, T., Fu, W., Moshier, E., Richter, J., Parekh, S., Jagannath, S., Chari, A., Rossi, A. C., Sanchez, L. J., Thibaud, S., Rodriguez, C., Cho, H. J. & Richard, S., May 2026, In: Bone Marrow Transplantation. 61, 5, p. 639-641 3 p.Research output: Contribution to journal › Letter › peer-review
-
Comparative cost per responder analysis of ciltacabtagene autoleucel and real-world standard of care therapy in patients with lenalidomide-refractory multiple myeloma
Hansen, D. K., Lu, X., Castaneda Puglianini, O., Zhang, E., Usmani, S. Z., Sachdev, R., Perciavalle, M., De Wiest, D., Huo, S., Lee, S., Qureshi, Z. P. & Jagannath, S., 2026, In: Expert Review of Pharmacoeconomics and Outcomes Research. 26, 3, p. 369-378 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Environmental exposures and multiple myeloma risk: A contemporary review of epidemiologic associations and mechanistic plausibility
del Rosal, M. V., He, M. Z., Jagannath, S., Parekh, S., Kloog, I., Arora, M. & Thibaud, S., 2026, (Accepted/In press) In: Blood Reviews. 101392.Research output: Contribution to journal › Review article › peer-review
Open Access -
Linvoseltamab in Patients With Relapsed/Refractory Multiple Myeloma in the LINKER-MM1 Study: Longer Follow-Up and Subgroup Analyses
Lee, H. C., Zonder, J. A., Dhodapkar, M. V., Jagannath, S., Hoffman, J. E., Suvannasankha, A., Shah, M. R., Lentzsch, S., Baz, R., Maly, J. J., Namburi, S., Pianko, M. J., Ye, J. C., Wu, K. L., Silbermann, R., Min, C. K., Vekemans, M. C., Munder, M., Byun, J. M. & Martínez-Lopez, J. & 11 others, , Feb 2026, In: Clinical Lymphoma, Myeloma and Leukemia. 26, 2, p. e201-e212.e8Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations
Press/Media
-
Recent Findings from Icahn School of Medicine at Mount Sinai Advance Knowledge in Multiple Myeloma (Effect of intravenous immunoglobulin on infections in multiple myeloma patients receiving daratumumab)
Moshier, E., Sastow , D., Richter, J., Lancman, G., Parekh, S., Jagannath, S., Chari, A., Cho, H. & Rodriguez, C.
30/04/26
1 item of Media coverage
Press/Media
-
-
It gives cancer patients like me hope. But some fear it’s irresponsible to say it.
29/03/26 → 30/03/26
2 items of Media coverage
Press/Media
-
BCMA-Directed Bispecific Antibodies Navigating a New Era in Relapsed/Refractory Multiple Myeloma
21/03/26
1 item of Media coverage
Press/Media